351 related articles for article (PubMed ID: 28442408)
1. Plasma membrane activatable polymeric nanotheranostics with self-enhanced light-triggered photosensitizer cellular influx for photodynamic cancer therapy.
Jia HR; Jiang YW; Zhu YX; Li YH; Wang HY; Han X; Yu ZW; Gu N; Liu P; Chen Z; Wu FG
J Control Release; 2017 Jun; 255():231-241. PubMed ID: 28442408
[TBL] [Abstract][Full Text] [Related]
2. Plasma membrane-anchorable photosensitizing nanomicelles for lipid raft-responsive and light-controllable intracellular drug delivery.
Jia HR; Zhu YX; Xu KF; Liu X; Wu FG
J Control Release; 2018 Sep; 286():103-113. PubMed ID: 30026079
[TBL] [Abstract][Full Text] [Related]
3. Tumor-homing photosensitizer-conjugated glycol chitosan nanoparticles for synchronous photodynamic imaging and therapy based on cellular on/off system.
Lee SJ; Koo H; Lee DE; Min S; Lee S; Chen X; Choi Y; Leary JF; Park K; Jeong SY; Kwon IC; Kim K; Choi K
Biomaterials; 2011 Jun; 32(16):4021-9. PubMed ID: 21376388
[TBL] [Abstract][Full Text] [Related]
4. Specific light-up pullulan-based nanoparticles with reduction-triggered emission and activatable photoactivity for the imaging and photodynamic killing of cancer cells.
Xia J; Zhang L; Qian M; Bao Y; Wang J; Li Y
J Colloid Interface Sci; 2017 Jul; 498():170-181. PubMed ID: 28324723
[TBL] [Abstract][Full Text] [Related]
5. Efficient anti-tumor effect of photodynamic treatment with polymeric nanoparticles composed of polyethylene glycol and polylactic acid block copolymer encapsulating hydrophobic porphyrin derivative.
Ogawara K; Shiraishi T; Araki T; Watanabe T; Ono T; Higaki K
Eur J Pharm Sci; 2016 Jan; 82():154-60. PubMed ID: 26593985
[TBL] [Abstract][Full Text] [Related]
6. Cholesterol-Assisted Bacterial Cell Surface Engineering for Photodynamic Inactivation of Gram-Positive and Gram-Negative Bacteria.
Jia HR; Zhu YX; Chen Z; Wu FG
ACS Appl Mater Interfaces; 2017 May; 9(19):15943-15951. PubMed ID: 28426936
[TBL] [Abstract][Full Text] [Related]
7. 5-aminolevulinic acid-incorporated nanoparticles of methoxy poly(ethylene glycol)-chitosan copolymer for photodynamic therapy.
Chung CW; Chung KD; Jeong YI; Kang DH
Int J Nanomedicine; 2013; 8():809-19. PubMed ID: 23589688
[TBL] [Abstract][Full Text] [Related]
8. Photosensitizer-Doped and Plasma Membrane-Responsive Liposomes for Nuclear Drug Delivery and Multidrug Resistance Reversal.
Zhu YX; Jia HR; Duan QY; Liu X; Yang J; Liu Y; Wu FG
ACS Appl Mater Interfaces; 2020 Aug; 12(33):36882-36894. PubMed ID: 32666795
[TBL] [Abstract][Full Text] [Related]
9. A Cell Membrane-Targeting Self-Delivery Chimeric Peptide for Enhanced Photodynamic Therapy and In Situ Therapeutic Feedback.
Ma W; Sha SN; Chen PL; Yu M; Chen JJ; Huang CB; Yu B; Liu Y; Liu LH; Yu ZQ
Adv Healthc Mater; 2020 Jan; 9(1):e1901100. PubMed ID: 31763796
[TBL] [Abstract][Full Text] [Related]
10. Nanoscopic micelle delivery improves the photophysical properties and efficacy of photodynamic therapy of protoporphyrin IX.
Ding H; Sumer BD; Kessinger CW; Dong Y; Huang G; Boothman DA; Gao J
J Control Release; 2011 May; 151(3):271-7. PubMed ID: 21232562
[TBL] [Abstract][Full Text] [Related]
11. Mitochondria and plasma membrane dual-targeted chimeric peptide for single-agent synergistic photodynamic therapy.
Cheng H; Zheng RR; Fan GL; Fan JH; Zhao LP; Jiang XY; Yang B; Yu XY; Li SY; Zhang XZ
Biomaterials; 2019 Jan; 188():1-11. PubMed ID: 30312907
[TBL] [Abstract][Full Text] [Related]
12. Bioorthogonal Pretargeting Strategy for Anchoring Activatable Photosensitizers on Plasma Membranes for Effective Photodynamic Therapy.
Wei R; Dong Y; Tu Y; Luo S; Pang X; Zhang W; Yao W; Tang W; Yang H; Wei X; Jiang X; Yuan Y; Yang R
ACS Appl Mater Interfaces; 2021 Mar; 13(12):14004-14014. PubMed ID: 33728894
[TBL] [Abstract][Full Text] [Related]
13. Photodynamic PEG-coated ROS-sensitive prodrug nanoassemblies for core-shell synergistic chemo-photodynamic therapy.
Sun B; Chen Y; Yu H; Wang C; Zhang X; Zhao H; Chen Q; He Z; Luo C; Sun J
Acta Biomater; 2019 Jul; 92():219-228. PubMed ID: 31078764
[TBL] [Abstract][Full Text] [Related]
14. Versatile RBC-derived vesicles as nanoparticle vector of photosensitizers for photodynamic therapy.
Wang LY; Shi XY; Yang CS; Huang DM
Nanoscale; 2013 Jan; 5(1):416-21. PubMed ID: 23187860
[TBL] [Abstract][Full Text] [Related]
15. Tumor specificity and therapeutic efficacy of photosensitizer-encapsulated glycol chitosan-based nanoparticles in tumor-bearing mice.
Lee SJ; Park K; Oh YK; Kwon SH; Her S; Kim IS; Choi K; Lee SJ; Kim H; Lee SG; Kim K; Kwon IC
Biomaterials; 2009 May; 30(15):2929-39. PubMed ID: 19254811
[TBL] [Abstract][Full Text] [Related]
16. Development of a functionalized UV-emitting nanocomposite for the treatment of cancer using indirect photodynamic therapy.
Sengar P; Juárez P; Verdugo-Meza A; Arellano DL; Jain A; Chauhan K; Hirata GA; Fournier PGJ
J Nanobiotechnology; 2018 Feb; 16(1):19. PubMed ID: 29482561
[TBL] [Abstract][Full Text] [Related]
17. Simple nanophotosensitizer fabrication using water-soluble chitosan for photodynamic therapy in gastrointestinal cancer cells.
Jeong YI; Cha B; Lee HL; Song YH; Jung YH; Kwak TW; Choi C; Jeong GW; Nah JW; Kang DH
Int J Pharm; 2017 Oct; 532(1):194-203. PubMed ID: 28888976
[TBL] [Abstract][Full Text] [Related]
18. Optimization of protoporphyrin IX skin delivery for topical photodynamic therapy: Nanodispersions of liquid-crystalline phase as nanocarriers.
Rossetti FC; Depieri LV; Praça FG; Del Ciampo JO; Fantini MC; Pierre MB; Tedesco AC; Bentley MV
Eur J Pharm Sci; 2016 Feb; 83():99-108. PubMed ID: 26657201
[TBL] [Abstract][Full Text] [Related]
19. Killing malignant melanoma cells with protoporphyrin IX-loaded polymersome-mediated photodynamic therapy and cold atmospheric plasma.
Wang M; Geilich BM; Keidar M; Webster TJ
Int J Nanomedicine; 2017; 12():4117-4127. PubMed ID: 28615940
[TBL] [Abstract][Full Text] [Related]
20. Oxygen Self-Sufficient Core-Shell Metal-Organic Framework-Based Smart Nanoplatform for Enhanced Synergistic Chemotherapy and Photodynamic Therapy.
Ren SZ; Wang B; Zhu XH; Zhu D; Liu M; Li SK; Yang YS; Wang ZC; Zhu HL
ACS Appl Mater Interfaces; 2020 Jun; 12(22):24662-24674. PubMed ID: 32394704
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
